September 13 [Wed.]
10F 1006 Conference Room
13:00
〜
17:00
【F-5】Osaka Chamber of Commerce and Industry
Global Venture Forum (GVF) 2006 Business plan presentations by high-tech Bio-venture companies from overseas
Wide range of 6 selected Bio-ventures : drug discovery, diagnostic and therapeutic technologies, etc.
● Advancing Genetic Medicine with Targeted Injectable Delivery
Systems to Treat Solid Cancer Tumors Epeius Biotechnologies Corporation ［USA］
● Development and Marketing of Rapid One Step Allergen Test Xenith Biomed ［Ireland］
● Antiviral Drug Discovery Using a Novel Broad-spectrum,
Cell-based Screening Platform Apath, LLC ［USA］
● Drug Discovery driven by Innovative Sugar Chain Technology
and Gene Homologous Recombination Summit Glycoresearch Corporation ［Japan］
● Enabling rapid, cost-effective development and commercialization of cellular therapeutics with enhanced biological activity and efficacy
MaxCyte, Inc. ［USA］
● Japanese-Asian partnering opportunity for clinical-stage, novel agents to treat sleep maintenance insomnia, schizophrenia, treatment-induced dysfunctions in Parkinson's disease, osteoporosis, muscle wasting, and weight gain.
ACADIA Pharmaceuticals, Inc. ［USA］
10F 1007 Conference Room
13:00
〜
13:50
【G-5】Bioindustry Association of Korea(BAK) 1
● Searching for the business collaboration with Choong Wae
Pharma Yong Soo Ham ( CHOONGWAE PHARMA, Chief of Overseas
Business Department)
● The Perfect solution to keep your cells alive on the microscope Sung Hoe Chang (Live Cell Instrument, CTO)
14:00
〜
14:20
【G-7】Boehringer Ingelheim GmbH
● Boehringer Ingelheim's performance in biopharmaceuticals Barbara Esch ( Boehringer Ingelheim GmbH, Business Development Manager)
14:30
〜
15:50
【G-8】Metropolitan Biotechnology-Related Startups Network Moderator
Kunio Mimura (Japan Bioindustry Association, Director)
● Battlefront of PC SerfaceTechnology Hiroshi Katagiri (AI BIO-CHIPS, President)
● Nuclear Receptor Co-factor Screening System Haruki Mizukami (EnBioTec Laboratories, President & CEO)
● Research and Development of New Drug Candidates from
Cancer-related Genes Kensuke Tomita (OncoTherapy Science, President & CEO)
● Outsourcing Service of Gene Analysis, and Compact System for
Gene Analysis Hidekazu Sogo (J-Bio 21, Sales)
● Business Plan Keiichi Kiyota (Nimura Genetic Solutions, President)
16:00
〜
16:20
【G-11】MaxCyte
● Enabling rapid, cost-effective development and commercialization of cellular therapeutics with enhanced biological activity and efficacy
Douglas Kolodny-Hirsch ( MaxCyte, Inc., Senior Director, Business Development)
16:30
〜16:50
【G-12】IBPC Osaka Investment Promotion Center Prize Winner (1) - Osaka City BIO-TECH Business Plan Competition
● Biocom Heart Rate Variability Products-Present and Future of
Professional HRV Assessmen Norio Nakahara ( Biocom Technologies, Representative for Japan, Board of Director
)
September 14 [Thu.]
10F 1006 Conference Room
9:30
〜
12:15
【F-13】France Biotechnology Day 2 Moderator
Michel Rosenberg (French Embassy in Japan, Economic Attache, Biotechnology & Life Science, Economic Department in Tokyo)
● Advanced Technologies in Molecular Biology & Improvement of
assay quality) Takeshi Hara ( bioMerieux Japan, Advanced Technologies in
Molecular Biology & Improvement of assay quality
● Research & Development of pharmaceuticals. in the field of Drug
Delivery System Jerome Besse (Galenix, Chairman)
●The ultimate High Content Screening response Francois Conquet (Fluofarma, Head of Business Development)
●An optimized approach of the use of in vitro models for a CNS drug Yves Wendzinski (Cellial Technologies, Chairman & CEO)
●A world leader in yeast and bakering ingredients, yeast extracts Jean-Luc Simon (Lesaffre International, General Manager)
●The protein turnover company Erwan Martin (Cytomics Systems, CFO)
● Providing Life Sciences Companies with solutions for Optimal
Bioavailability Innovation in ADME & Biopharmaceutical Sciences Jean Pachot (Oroxcell, President & CSO)
● Software solutions to identify affinity and selectivity mechanisms
between drug candidates and 3D molecular target Francois Delfaud (Medit, CEO)
●An innovative solution to develop poorly soluble APIs Fabrice Le Borg ( Pierre Fabre Medicament, Business Development Manager)
● The Financing and Managing of European and International
health science projects Caroline Gans-Combe ( Inserm Transfert, Director of European &
International Affairs)
13:00
〜
14:20
【F-17】Bioindustry Association of Korea (BAK) 2
●Accelerating Drug Discovery using Structural ChemProteomics Joong Myung Cho (Crystal Genomics, CEO & President)
●Earning AAALAC Accreditation of Laboratory Micro-Pig Care Myeong Seop Lee (PWG, Ltd., Research Director)
●Insulin inhaler using insulin microcrystals Kim Chan-Wha (Mitech Inc., President)
14:30
〜
14:50
【F-20】MorphoSys
● HuCAL : Fully Human Antibody Therapeutics Against Challenging
Targets Laurence Barker ( MorphoSys AG, Manager Business
Development)
15:00
〜
15:20
【F-21】Kagawa Industry Support Foundation
● "Rare Sugars" Production method, Application and Business
trend Takeo Takahashi ( Takamatsu Regional Intellectual Cluster
Headquarters, Kagawa Industry Support Foundation, Commercialization Manager)
15:30
〜
15:50
【F-22】State of Illinois
● US market entry strategy for biotech firm and the role of
outsourcing in the U.S. Michael Rosen ( Illinois Science + Technology Park, Senior Vice-President)
●US Market Entry Through Collaboration Eric Waehner ( TAP Pharmaceutical Products, Business Development Executive)
16:00
〜
16:50
【F-23】The Sponsor's Program Partnering Session
● Partnering between bio-ventures and Japanese pharmaceutical
companies Moderator
Motohiro Yamasaki ( Yamasaki Pharma Consulting, President &
CEO)
●Case Study : Partnering Strategy of Japanese Leading Pharma Hiroaki Ogata ( Takeda Pharmaceutical, Business Development &
Global Licensing Dept, GM & Corporate Officer) Hideki Hayashi ( Eisai, Corporate Business Development,
Vice President)
10F 1007 Conference Room
10:30
〜
16:45
【G-13】NPO KINKI BIO-INDUSTRY DEVELOPMENT ORGANIZATION
●Universal procedure for refolding recombinant proteins Tomomi Umetsu (ProteoGenesys President)
● Introduction of new lighting source technology (HEFL) for plant
factories Akihisa Tsuji (Nihon Advanced Agri, Chief Executive Officer)
●CREDIA JAPAN Tomio Konaka ( CREDIA JAPAN Corporation, Director,
Business Manager)
● Drug Development Using Anti-Inflammatory Protein, TRX and its
Future Kazuo Murata (Redox Bio Science, President)
● Clinical Development of Recombinant Protein NK4 and HGF
Offering Novel Therapeutic for Severe Disease Patients Kiichi Adachi ( Kringle Pharma, Executive Vice President, Director of Business Development)
●Innovative Biomaterial for Tissue Engineering Nobuhiko Yagi (MedGel, Director) Luncheon Seminar
●The existing condition and future of AnGes MG Ei Yamada (AnGes MG, Inc., President & CEO)
● Development of prosthetic implant and technology expansion
into other medical equipments Hiroo Nakagawa (Nara Seiko, President)
●Development of medical image network system Noboru Yamamoto (Climb Medical Systems, President & CEO)
●Crystallization service by novel technology Hiroaki Adachi (SOSHO, President)
● Development of a consultation program for diabetes mellitus
utilizing SNP data, and our future vision Muneo Takiguchi ( Signpost, Director of Research and Development
& General Manager of Clinical Research Division)
●Carna's kinase related drug discovery Support services Hiroshi Ishiguro (Carna Biosciences, CTO)
● Beacle - a venture company leading way for the eradication of
hepatic diseases Keijiro Tanigawa (Beacle, CEO & President)
● Development and Application of Mucosal Vaccine Candidates
Using a Novel Lactic Acid Bacteria Display System Tomomitsu Sewaki (GenoLac BL, President)
●Functional foods and biomarker Kouji Nishikawa (Biomarker Science, President)
●Development of the delivery system for genetic medicines Toshihiro Nakajima ( GenomIdea, CTO)
●Bio Business of KNC Laboratories Takashi Harimoto ( KNC Laboratories,
Director Business Development)
●New separation media using porous silica gel Hiroyoshi Minakuchi (Kyoto Monotech, President)
● Tha Dawn of Carbon Dioxide Therapy; Innovative Technology for
Treatment of Decubitus and Intractable Ulcer Masaya Tanaka (NeoChemir, President)
● Manufacture and application of Japanese radish extract
containing antifreeze protein Hidehisa Kawahara ( BICC World/Kansai University, Director /Associate Professor)
●Synthetic Collagen Takako Kita (PHG, RESEARCHER)
September 15 [Fri.]
10F 1006 Conference Room
10:30
〜10:50
【F-25】SC World
●Monoclonal antibody development by cell screening system Takeshi Oishi ( SC World Sales Engineer, Antibody Project, Advanced System Division)
11:00
〜
11:20
【F-26】International Science and Technology Center
●Advanced Biotechnology in Russia/CIS. ISTC programs and
services to convert R&D into sustainable business Natalya Savinova ( International Science and Technology Center, Partner Project Manager (Bioindustry)) 11:30
〜
11:50
【F-27】SCYNEXIS
●Product Partnering With SCYNEXIS Yves Ribeill (SCYNEXIS, Inc. President & CEO)
12:00
〜
12:20
【F-28】Locus Pharmaceuticals
●Revolutionary Science Accelerating Tomorrow's Medicine Robert Dickey IV ( Locus Pharmaceuticals, Vice President, Finance and CFO)
13:00
〜
15:20
【F-29】Hokkaido Bio TechnologyIndustrial Cluster Forum
●The development of cancer treatments targeting for adaptation
to hypoxia and nutrient-deprivation Hitoshi Kojo ( ONCOREX, Corporate Officer CSO Director of Institute and Director of Research Division)
●Development and Application of Chitin and Chitosan Tsuneo Ohkuma (HOKKAIDO SODA, General Manager)
●Outline of SIGMA-ALDRICH JAPAN and a brief introduction of
latest product Takuma Watanabe (SIGMA-ALDRICH JAPAN, R&D associate)
●Outline of Wide Area Bioresource System Masahiro Nakamura (DynmicBind, President)
●New Development of Rapid Genome Sequence Retrieval
System GenoQuester 2 Hiroki Arakawa (BIOMATICS, Director CTO)
●Introduction of Hokkaido STS Taku Satou (Hokkaido STS, Manager)
●Peptide suppressing food intake (suppressing appetite) Kozo Asano (A-HITBio, Science and technology adviser)
●Polycyclic Aromatic Hydrocarbons (PAHs) Removal Effect of
DNA and its Application Masaji Matsunaga (Nissei Bio, CEO)
●Support for development of medical devices Masaaki Kashima ( Safety Research Institute for Chemical Compounds, Director, Non-Clinical Division)
15:30
〜
15:50
【F-34】Asterand UK
●Accelerating Pre-clinical Drug Discovery Research using Human
Tissues Julian Beesley ( Asterand UK Ltd, Principal Scientist, Managing
Director, Japan) 16:00
〜
16:20
【F-35】Chiome Bioscience
●Rapid generation of monoclonal antibody by ADLib system Masaaki Fujiwara (Chiome Bioscience, Chief Exective Officer)
10F 1007 Conference Room
10:30
〜
10:50
【G-25】Baxter
●BAXTER's mammalian cell culture manufacturing and process
development services Axel Schleyer ( Baxter Bioscience, Business Development, Director)
11:00
〜
11:20
【G-26】IBPC Osaka Investment Promotion Center
●Prize Winner (2) - Osaka City BIO-TECH Business Plan Competition
High-water mark ant-virus material [BR-p3] and cloth
Kazuo Wakabayashi (Mochigase, President)
11:30
〜
11:50
【G-26】IBPC Osaka Investment Promotion Center
●Prize Winner (3) - Osaka City BIO-TECH Business Plan Competition "AtlanChim, Your Ideal Chemist Partner for Research"
Francis Cinget (AtlanChim, CEO)
13:00
〜
14:50
【G-29】Bio Factory Central Japan/Mie Medical Valley Project
●Quantification of itch useing acoustic analysis Koji Umeda (KSK laboratories, President)
●Invention of new drugs by use of complementary peptides to a
target molecule Hidechika Okada (Institute for Protein Science, M.D., PhD.)
●Supplement for Rheumatoid Arthritis RAease Tsuyoshi Ishida (Ishida Pharma, The chief executive officer)
●Application of Phase Contrast TEM for Biological Research Atsushi Kitayama (TerABase, CEO)
15:00
〜
15:50
【G-33】OKINAWA Industry Promotion Project
●Okinawan Pioneers of New Biotechnology for the Future OKINAWA Industry Promotion Project, Member Companies of Okinawa Industry Promotion Project Network
●Calshell, the food compositional materials protected by the husk
of calsium Akihiko Kurosaki (KITII, n.a.)
●Production of Plasmid DNA, for In Vitro Diagnostic Agents Masanao Kikukawa ( Advanced Medical Biological Science Institute, President)
●PepTenChip, a novel bio-chip in the next generation produced by
the HiPep Technologies Kiyoshi Nokihara ( HiPep Laboratories, Founder & CEO/CSO, OKINAWA General Bureau)
16:00
〜
16:20
【G-36】GenoMembrane
●Introducing applied transporter technology designed to facilitate
efficient drug development Hikaru Yabuuchi (GenoMembrane, Representative Director)